EGFR plays a pivotal role in the initiation, progression, and metastasis of tumor cells by activating many downstream pathways in CRC, such as RAS/RAF/MEK/ERK and PI3K/AKT/mTOR pathway 5. Here, AKT1 is linked to neoplasm.